Corpus ID: 11392102

FDA notifications. Reyataz is approved for HIV treatment.

@article{2003FDANR,
  title={FDA notifications. Reyataz is approved for HIV treatment.},
  author={},
  journal={AIDS alert},
  year={2003},
  volume={18 9},
  pages={
          119-20
        }
}
  • Published 2003
  • Medicine
  • AIDS alert
Reyataz, protease inhibitor, is to be used in combination with other antiretroviral agents for the treatment of patients with HIV infection. The most common laboratory abnormality observed is hyperbilirubinemia. 
2 Citations